Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mamogel cream versus hydrocortisone for mild to moderate irritant hand contact dermatitis
IRCT20250923067342N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of hydrocortisone in irritant contact dermatitis (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: HECSI score, Quality of life and 1 more. Started Oct 2025; status: completed.
02
Drugs
hydrocortisone
03
Conditions
irritant contact dermatitis
Beyond the preview
Go deeper on IRCT20250923067342N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250923067342N1.